Detalhe da pesquisa
1.
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trial.
Clin Exp Rheumatol
; 36 Suppl 113(4): 146-149, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30277862
2.
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
Lancet
; 387(10038): 2630-2640, 2016 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156934
3.
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
N Engl J Med
; 370(5): 433-43, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24350901
4.
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90.
Am J Pathol
; 186(10): 2650-64, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565038
5.
Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?
Curr Rheumatol Rep
; 18(1): 2, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26700912
6.
CpGB DNA activates dermal macrophages and specifically recruits inflammatory monocytes into the skin.
Exp Dermatol
; 24(2): 133-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425469
7.
Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
Ann Rheum Dis
; 73(10): 1864-72, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23873879
8.
Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor ß.
Arthritis Rheum
; 65(5): 1335-46, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23335246
9.
CXCL4 drives fibrosis by promoting several key cellular and molecular processes.
Cell Rep
; 38(1): 110189, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986347
10.
Local skin gene expression reflects both local and systemic skin disease in patients with systemic sclerosis.
Rheumatology (Oxford)
; 55(2): 377-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26342226
11.
The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments.
Nat Commun
; 12(1): 2856, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001893
12.
Progressive derangement of the T cell compartment in a case of Evans syndrome.
Int Arch Allergy Immunol
; 145(3): 258-67, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17921676
13.
Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin.
Front Immunol
; 9: 2191, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327649
14.
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.
Arthritis Rheumatol
; 70(6): 912-919, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858547
15.
A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin.
J Invest Dermatol
; 137(1): 62-70, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27640094
16.
Editorial: Etiopathogenesis of Systemic Sclerosis: An Update.
Front Immunol
; 12: 663381, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828566
17.
miR-155 in the progression of lung fibrosis in systemic sclerosis.
Arthritis Res Ther
; 18(1): 155, 2016 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377409
18.
A case of tension-type headache in fibromyalgia.
J Headache Pain
; 11(4): 367-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20454992
19.
Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.
Case Rep Med
; 2015: 294041, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26064125
20.
A longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis.
Arthritis Rheumatol
; 67(11): 3004-15, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26240058